SC79 - 98%, high purity , CAS No.305834-79-1

  • ≥98%
Item Number
S275934
Grouped product items
SKUSizeAvailabilityPrice Qty
S275934-5mg
5mg
In stock
$64.90
S275934-25mg
25mg
In stock
$292.90
S275934-100mg
100mg
In stock
$395.90
S275934-250mg
250mg
In stock
$891.90

Akt activator

View related series
Akt PI3K/Akt/mTOR

Basic Description

Specifications & Purity≥98%
Biochemical and Physiological MechanismsAkt activator. Binds to the pleckstrin homology domain. Suppress excitotoxicity-induced neuronal death. Shows neuroprotective effects in vivo . Blood-brain barrier permeable.
Storage TempStore at -20°C,Desiccated
Shipped InIce chest + Ice pads
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

Names and Identifiers

IUPAC Name ethyl 2-amino-6-chloro-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
INCHI InChI=1S/C17H17ClN2O5/c1-3-23-16(21)11(8-19)13-10-7-9(18)5-6-12(10)25-15(20)14(13)17(22)24-4-2/h5-7,11,13H,3-4,20H2,1-2H3
InChi Key DXVKFBGVVRSOLI-UHFFFAOYSA-N
Canonical SMILES CCOC(=O)C1=C(OC2=C(C1C(C#N)C(=O)OCC)C=C(C=C2)Cl)N
Isomeric SMILES CCOC(=O)C1=C(OC2=C(C1C(C#N)C(=O)OCC)C=C(C=C2)Cl)N
PubChem CID 2810830
Molecular Weight 364.8

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDateItem
L2207563Certificate of AnalysisSep 21, 2023 S275934
L2207645Certificate of AnalysisSep 21, 2023 S275934
L2207648Certificate of AnalysisSep 21, 2023 S275934
L2207973Certificate of AnalysisSep 21, 2023 S275934

Chemical and Physical Properties

SolubilitySoluble in DMSO to 100 mM

Related Documents

References

1. Niu S et al..  (2018)  Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism via the Akt-Dependent Pathway..  Int J Endocrinol,  2018  (4371396).  [PMID:29853881]
2. Nakao M et al..  (2021)  Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload..  Sci Rep,  11  (18384).  [PMID:34526601]
3. Zhao Y et al..  (2021)  Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway..  Mol Med Rep,  23  (6):   [PMID:33880579]
4. Wang F et al..  (2019)  lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3ß axis in hepatocellular carcinoma..  Cancer Manag Res,  11  (3813-3828).  [PMID:31118799]
5. Sun Z et al..  (2019)  Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis..  Clin Sci (Lond),  133  (10): (1167-1184).  [PMID:31076460]
6. Xu F et al..  (2018)  Pectolinarigenin inhibits non-small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway..  Oncol Rep,  40  (6): (3458-3468).  [PMID:30542737]
7. Cao Z et al..  (2021)  Silencing of NACC1 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via regulating the AKT/mTOR signaling pathway..  Oncol Lett,  22  (6): (828).  [PMID:34691255]
8. Gamero-Estevez E et al..  (2019)  Temporal Effects of Quercetin on Tight Junction Barrier Properties and Claudin Expression and Localization in MDCK II Cells..  Int J Mol Sci,  20  (19):   [PMID:31581662]

Solution Calculators